Please use this identifier to cite or link to this item: https://observatorio.fm.usp.br/handle/OPI/826
Full metadata record
DC FieldValueLanguage
dc.contributorSistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP-
dc.contributor.authorJANZ, Felipe de Lara-
dc.contributor.authorDEBES, Adriana de Aguiar-
dc.contributor.authorCAVAGLIERI, Rita de Cassia-
dc.contributor.authorDUARTE, Sergio Aloisio-
dc.contributor.authorROMAO, Carolina Martinez-
dc.contributor.authorMORON, Antonio Fernandes-
dc.contributor.authorZUGAIB, Marcelo-
dc.contributor.authorBYDLOWSKI, Sergio Paulo-
dc.date.accessioned2013-07-30T15:09:01Z-
dc.date.available2013-07-30T15:09:01Z-
dc.date.issued2012-
dc.identifier.citationJOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY, article ID 649353, 10p, 2012-
dc.identifier.issn1110-7243-
dc.identifier.urihttps://observatorio.fm.usp.br/handle/OPI/826-
dc.description.abstractAmniotic fluid (AF) was described as a potential source of mesenchymal stem cells (MSCs) for biomedicine purposes. Therefore, evaluation of alternative cryoprotectants and freezing protocols capable to maintain the viability and stemness of these cells after cooling is still needed. AF stem cells (AFSCs) were tested for different freezing methods and cryoprotectants. Cell viability, gene expression, surface markers, and plasticity were evaluated after thawing. AFSCs expressed undifferentiated genes Oct4 and Nanog; presented typical markers (CD29, CD44, CD90, and CD105) and were able to differentiate into mesenchymal lineages. All tested cryoprotectants preserved the features of AFSCs however, variations in cell viability were observed. In this concern, dimethyl sulfoxide (Me2SO) showed the best results. The freezing protocols tested did not promote significant changes in the AFSCs viability. Time programmed and nonprogrammed freezing methods could be used for successful AFSCs cryopreservation for 6 months. Although tested cryoprotectants maintained undifferentiated gene expression, typical markers, and plasticity of AFSCs, only Me2SO and glycerol presented workable viability ratios.-
dc.description.sponsorshipConselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)-
dc.description.sponsorshipFinanciadora de Estudos e Projetos (FINEP)-
dc.description.sponsorshipInstituto Nacional de Ciencia e Tecnologia-Fluidos Complexos (INCT-FCx), Brazil-
dc.language.isoeng-
dc.publisherHINDAWI PUBLISHING CORPORATION-
dc.relation.ispartofJournal of Biomedicine and Biotechnology-
dc.rightsopenAccess-
dc.subject.otherdifferentiation protocols-
dc.subject.othermarrow-
dc.subject.otherblood-
dc.subject.otherexpression-
dc.subject.othertoxicity-
dc.titleEvaluation of Distinct Freezing Methods and Cryoprotectants for Human Amniotic Fluid Stem Cells Cryopreservation-
dc.typearticle-
dc.rights.holderCopyright HINDAWI PUBLISHING CORPORATION-
dc.identifier.doi10.1155/2012/649353-
dc.identifier.pmid22665987-
dc.subject.wosBiotechnology & Applied Microbiology-
dc.subject.wosMedicine, Research & Experimental-
dc.type.categoryoriginal article-
dc.type.versionpublishedVersion-
hcfmusp.author.externalDEBES, Adriana de Aguiar:Fundacao Prosangue Hemoctr Sao Paulo, BR-05403000 Sao Paulo, Brazil-
hcfmusp.author.externalDUARTE, Sergio Aloisio:Univ Sao Paulo, Sch Med, Dept Gynecol & Obstet, BR-05403000 Sao Paulo, Brazil-
hcfmusp.author.externalMORON, Antonio Fernandes:Univ Fed Sao Paulo, Sch Med, Dept Obstet, BR-04021001 Sao Paulo, Brazil-
hcfmusp.description.articlenumber649353-
hcfmusp.description.volume2012-
hcfmusp.origemWOS-
hcfmusp.origem.id2-s2.0-84862292313-
hcfmusp.origem.idWOS:000304937000001-
hcfmusp.publisher.cityNEW YORK-
hcfmusp.publisher.countryUSA-
hcfmusp.relation.referenceAbdallah BM, 2008, GENE THER, V15, P109, DOI 10.1038/sj.gt.3303067-
hcfmusp.relation.referenceARNAUD FG, 1989, THROMB RES, V53, P585, DOI 10.1016/0049-3848(89)90148-5-
hcfmusp.relation.referenceBarzilay R, 2008, STEM CELLS DEV, V17, P547, DOI 10.1089/scd.2007.0172-
hcfmusp.relation.referenceDAVIS JM, 1990, BLOOD, V75, P781-
hcfmusp.relation.referenceFauza D, 2004, BEST PRACT RES CL OB, V18, P877, DOI 10.1016/j.bpobgyn.2004.07.001-
hcfmusp.relation.referenceFRIEDENS.AJ, 1974, EXP HEMATOL, V2, P83-
hcfmusp.relation.referenceIn 't Anker PS, 2003, BLOOD, V102, P1548-
hcfmusp.relation.referenceKolf CM, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2116-
hcfmusp.relation.referenceLiu WX, 2009, REPROD DOMEST ANIM, V44, P788, DOI 10.1111/j.1439-0531.2008.01078.x-
hcfmusp.relation.referenceMareschi K, 2006, EXP HEMATOL, V34, P1563, DOI 10.1016/j.exphem.2006.06.020-
hcfmusp.relation.referenceMcCullough J, 2010, TRANSFUSION, V50, P808, DOI 10.1111/j.1537-2995.2009.02482.x-
hcfmusp.relation.referenceMiranda-Sayago J. M., CRYOBIOLOGY IN PRESS-
hcfmusp.relation.referenceMoon JH, 2008, HUM REPROD, V23, P1760, DOI 10.1093/humrep/den202-
hcfmusp.relation.referenceNeuhuber B, 2004, J NEUROSCI RES, V77, P192, DOI 10.1002/jnr.20147-
hcfmusp.relation.referenceOzkavukcu S., 2002, J ANKARA MED SCH, V4, P187-
hcfmusp.relation.referencePrusa A-R., 2002, MED SCI MONITOR, V8, P253-
hcfmusp.relation.referencePrusa AR, 2004, AM J OBSTET GYNECOL, V191, P309, DOI 10.1016/j.ajog.2003.12.014-
hcfmusp.relation.referencePrusa AR, 2003, HUM REPROD, V18, P1489, DOI 10.1093/humrep/deg279-
hcfmusp.relation.referenceRodrigues JP, 2008, CRYOBIOLOGY, V56, P144, DOI 10.1016/j.cryobiol.2008.01.003-
hcfmusp.relation.referenceRoubelakis MG, 2007, STEM CELLS DEV, V16, P931, DOI 10.1089/scd.2007.0036-
hcfmusp.relation.referenceSeo JM, 2011, CRYOBIOLOGY, V62, P167, DOI 10.1016/j.cryobiol.2011.02.003-
hcfmusp.relation.referenceShi YF, 2010, CELL RES, V20, P510, DOI 10.1038/cr.2010.44-
hcfmusp.relation.referenceSputtek A, 1997, BEITR INFUS, V34, P79-
hcfmusp.relation.referenceStock P, 2010, NAT PROTOC, V5, P617, DOI 10.1038/nprot.2010.7-
hcfmusp.relation.referenceSTREUBEL, 1996, WIEN MED WOCHENSCHR, V146, P216-
hcfmusp.relation.referenceSTRONCEK DF, 1991, TRANSFUSION, V31, P521, DOI 10.1046/j.1537-2995.1991.31691306250.x-
hcfmusp.relation.referenceSyme R, 2004, BIOL BLOOD MARROW TR, V10, P135, DOI 10.1016/j.bbmt.2003.09.016-
hcfmusp.relation.referenceTsai MS, 2004, HUM REPROD, V19, P1450, DOI 10.1093/humrep/deh279-
hcfmusp.relation.referenceZangrossi S, 2007, STEM CELLS, V25, P1675, DOI 10.1634/stemcells.2006-0611-
dc.description.indexMEDLINE-
hcfmusp.remissive.sponsorshipCNPq-
hcfmusp.remissive.sponsorshipFederico Foundation-
hcfmusp.remissive.sponsorshipINCTs-
hcfmusp.remissive.sponsorshipFINEP-
hcfmusp.lim.ref2012-
hcfmusp.citation.scopus46-
hcfmusp.scopus.lastupdate2022-07-29-
Appears in Collections:

Artigos e Materiais de Revistas Científicas - FM/MCM
Departamento de Clínica Médica - FM/MCM

Artigos e Materiais de Revistas Científicas - FM/MOG
Departamento de Obstetrícia e Ginecologia - FM/MOG

Artigos e Materiais de Revistas Científicas - HC/ICHC
Instituto Central - HC/ICHC

Artigos e Materiais de Revistas Científicas - LIM/31
LIM/31 - Laboratório de Genética e Hematologia Molecular

Artigos e Materiais de Revistas Científicas - LIM/57
LIM/57 - Laboratório de Fisiologia Obstétrica


Files in This Item:
File Description SizeFormat 
art_JANZ_Evaluation_of_Distinct_Freezing_Methods_and_Cryoprotectants_for_2012.PDFpublishedVersion (English)1.94 MBAdobe PDFThumbnail
View/Open

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.